HHV8 antibody
Quick Overview for HHV8 antibody (ABIN264910)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Specificity
- Cyclin
-
Purification
- Ammonium Sulfate Precipitation
-
Immunogen
- Inclusion Bodies from E. Coli expressing his-tagged full length Human cyclin G2 protein.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Immunoblotting: 1 - 5 μg/mL. Immunoprecipitation: 10 - 20 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 0.08 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store the antibody (in aliquots) at -20 °C.
-
-
-
: "Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma." in: Oncogene, Vol. 27, Issue 4, pp. 421-33, (2008) (PubMed).
: "Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter." in: Blood, Vol. 105, Issue 6, pp. 2356-63, (2005) (PubMed).
: "KSHV viral cyclin binds to p27KIP1 in primary effusion lymphomas." in: Blood, Vol. 104, Issue 10, pp. 3349-54, (2004) (PubMed).
-
-
- HHV8 (Herpes Virus Type 8 (HHV8))
-
Alternative Name
- Herpes Virus Type 8 / HHV8
-
Target Type
- Virus
-
Background
- Human herpervirus-8 (HHV-8) cyclin is a component of the HHV-8 virus particle. HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.Synonyms: HHV-8, KHSV
-
Molecular Weight
- 28.1 kDa
Target
-